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ABSTRACT
Objectives This study aimed to explore the degree 
to which non- pharmacological strategies for chronic 
breathlessness are sustained 6 months after completing a 
breathlessness service in patients with chronic obstructive 
pulmonary disease (COPD), and patient perceptions 
regarding the need for ongoing support.
Design A qualitative approach was taken using 
semistructured telephone interviews. Thematic analysis 
used an integrative approach.
Setting The Westmead Breathlessness Service (WBS) 
trains patients with COPD to self- manage chronic 
breathlessness over an 8- week programme with 
multidisciplinary input and home visits.
Participants Patients with moderate to very severe COPD 
who had completed the WBS programme 6 months earlier.
Results Thirty- two participants were interviewed. One 
or more breathlessness self- management strategies 
were sustained by most participants, including breathing 
techniques (n=22; 69%), the hand- held fan (n=17; 
53%), planning/pacing and exercise (n=14 for each; 
44%) and strategic use of a four- wheeled walker (n=8; 
25%). However, almost a third of participants appeared 
to be struggling psychologically, including some who had 
refused psychological intervention. A ‘chaos narrative’ 
appeared to be prevalent, and many participants had poor 
recall of the programme.
Conclusions Self- management strategies taught by 
breathlessness services to patients with moderate to very 
severe COPD have potential to be sustained 6 months later. 
However, psychological coping may be more challenging 
to maintain. Research is needed on ways to improve 
resilience to set- backs and uptake of psychological 
interventions, as well as to understand and address the 
implications of poor recall for self- management.
Trial registration number ACTRN12617000499381
INTRODUCTION
Chronic breathlessness is a debilitating 
syndrome in people with chronic obstruc-
tive pulmonary disease (COPD) that persists 
despite optimised, guideline- concordant 
pharmacological treatment of the underlying 
medical condition(s).1 Although chronic 
breathlessness cannot be cured, it can be 
managed with both non- pharmacological 
and pharmacological therapies aimed at 
modulating the perception of breathless-
ness and the individual’s response.2 These 
therapies are ideally delivered within a self- 
management framework in which people 
learn skills to reduce the impact on func-
tioning and to sustain their emotional well- 
being.3 4
The ‘breathlessness service’ has emerged as 
a new model of care for chronic breathless-
ness in which expert multidisciplinary teams 
train patients to self- manage using a range 
of non- pharmacological therapies, including 
breathing techniques, exercise/physical 
activity, planning and pacing, a hand- held 
fan and relaxation strategies.5 Clinical trials 
have identified benefits to breathlessness- 
related distress and depression and, to a 
lesser degree, breathlessness mastery and 
Strength and limitations of this study
 ► This is the first study to examine 6- month main-
tenance of non- pharmacological strategies learnt 
through a breathlessness service, and to focus on 
a breathlessness service developed specifically for 
patients with chronic obstructive pulmonary disease 
(COPD).
 ► The focus on patients with COPD is both a strength 
and limitation, enabling an in- depth understanding 
of challenges faced by this patient population but 
limiting generalisability to other populations who 
may benefit from breathlessness services.
 ► Problems with recall shown by many participants 
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severity, and anxiety.6 7 Qualitative substudies from these 
trials have found that many participants reported benefits 
from reduced panic and increased confidence even when 
quantitative results for distress due to breathlessness and 
anxiety/depression were not significant.8 However, no 
study to date has examined whether patients’ use of the 
non- pharmacological strategies and related benefits are 
sustained beyond the immediate intervention period.
This study aimed to explore the degree to which non- 
pharmacological strategies and patient- perceived benefits 
were sustained 6 months after completing a breathless-
ness service designed for patients with moderate to very 
severe COPD, as well as patient perceptions regarding the 
need for ongoing support.
METHODS
The subjective, multidimensional nature of chronic 
breathlessness warranted a qualitative approach. 
Reporting of the study has been guided by the Consol-
idated Criteria for Reporting Qualitative Research.9 All 
participants gave written informed consent to participate.
Setting
The study focused on a breathlessness service in Western 
Sydney, Australia. The Westmead Breathlessness Service 
(WBS) is run over 8 weeks (plus preassessments and 
postassessments) through a respiratory medicine outpa-
tient service at a metropolitan hospital providing tertiary 
and quaternary services to a socioeconomically and cultur-
ally diverse population. The WBS offers multidisciplinary 
support from a physician, two nurses, a physiotherapist, 
an occupational therapist and dietitian, providing both 
outpatient and in- home individualised sessions. To be 
eligible for the WBS, patients need to have moderate to 
very severe COPD (defined as forced expiratory volume 
in 1 s (FEV1)/ forced vital capacity ≤70%; FEV1 ≤60% 
predicted), moderate to severe breathlessness (Modified 
Medical Research Council Dyspnoea Scale10 score ≥2), 
and be assessed as willing and able to actively participate in 
their own care by the WBS team.11Patients are referred to 
the WBS by respiratory specialists, general practitioners, 
nurses and allied health personnel. Previous attendance 
at pulmonary rehabilitation is encouraged, but patients 
who were unable to attend for various reasons are still 
eligible for referral. After completing the programme, 
patients are encouraged to contact the WBS again by tele-
phone whenever they require further support. Patients 
who are identified by standardised screening as being 
at risk for depression and/or anxiety at the end of the 
initial 8- week programme, and who accept referral, are 
seen by a psychologist for six to eight sessions of cogni-
tive behavioural therapy (CBT) over a 10- week period. 
Patients may also be visited by a member of the WBS team 
if they are admitted to Westmead Hospital and the WBS 
team becomes aware of their admission.
Recruitment for a randomised controlled trial eval-
uating WBS is currently underway, with the primary 
endpoint being mastery of breathlessness as measured 
by the Chronic Respiratory Questionnaire.12 A detailed 
protocol has recently been published.11 For the trial, 
patients are followed up by telephone 3 and 6 months 
after they complete the WBS programme for outcome 
measurement by a WBS trials nurse who is not involved 
in their care. This article reports on results from the 
6- month follow- up time- point of the trial’s qualitative 
substudy. Results from the first time- point of the qualita-
tive substudy (n=41) have been reported elsewhere and 
focused on patient perceptions of benefits derived from 
the service and ideas for improvement.13
Sample
Participants were drawn from consecutive patients who 
completed the WBS programme between June 2017 and 
September 2019 and had been interviewed at the first 
time- point. The sample size for the first time- point was 
determined by ‘information power’.14 For the second 
time- point, we interviewed everyone in the initial sample 
who agreed to be interviewed again and could be 
contacted.
Data collection
Semistructured interviews were conducted by telephone 
approximately 6 months after completing the WBS 
programme. Questions focused on participant percep-
tions regarding their overall health status compared 
with when they completed the programme; the degree 
to which they were still using the strategies they learnt 
through the WBS and deriving benefit from them and 
considerations regarding continued contact with the 
WBS. Interviews were conducted by a male social scien-
tist with experience in qualitative research (TL), who was 
employed as a university academic and had no previous 
or continuing relationships with participants other than 
conducting the initial interview following WBS comple-
tion. We explained to participants that our research was 
aimed at improving the WBS for future patients. Inter-
views were audio- recorded and field notes were made. 
Data were transcribed and managed using NVivo V.12 
software (QSR International).
To provide context, data were extracted from patients’ 
medical records regarding contact with the WBS since 
the time of their first interview, as well as from the trial 
dataset on participant age, living alone status, use of long- 
term oxygen therapy, attendance at pulmonary rehabili-
tation, and performance on a range of clinical tests and 
measures of breathlessness, anxiety and depression.
Analysis
Thematic analysis used an integrative method designed 
for informing the development of health service inter-
ventions.15 This method uses both inductive and deduc-
tive approaches to build on previous research while 
remaining open to new insights. The initial coding 
structure was defined by the study’s aims and interview 
questions. It was decided that coding of interviews would 
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benefit from both WBS ‘insider’ and ‘outsider’ perspec-
tives to reduce confirmation bias while also ensuring that 
interpretations were informed by a deep understanding 
of the service. Analyses were therefore conducted inde-
pendently by two researchers who then met to discuss any 
disagreements: TL and a female respiratory clinical nurse 
consultant involved in delivering the WBS (MR or VS). 
As well as being analysed thematically, each transcript was 
rated by two independent reviewers (TL and MR or VS) 
for whether the participant reported their overall health 
status to be better, worse or unchanged compared with 
when they complete the programme, taking into account 
the entire interview. Neither transcripts nor emerging 
themes were returned to participants for verification.
RESULTS
Thirty two of the 41 (78%) participants who were inter-
viewed at the first time- point were interviewed at the 
second time- point. Of the original sample, 15/18 partic-
ipants who reported ‘significant’ benefit at the first time- 
point participated, 13/17 who reported ‘some’ benefit, 
2/2 who reported ‘no’ benefit and 2/4 who were difficult 
to code were interviewed for this study. Nine of the orig-
inal participants were not re- interviewed; four patients 
could not be contacted despite multiple attempts by tele-
phone, three had died in the intervening period, and two 
refused, one of whom cited poor health as the reason. 
Interviews took place at a median of 194 days following 
the first interview (IQR, 188–210 days) and ranged from 
6min to 36 min in length. See table 1 for participant 
characteristics.
Compared with when they had completed the WBS 
programme, four participants were rated by researchers 
after reading their entire transcript as reporting their 
overall health status to be better (12.5%), four unchanged 
(12.5%) and eight worse (25%). The remaining 16 partic-
ipants (50%) were either uncertain about their change in 
health status or else made contradictory statements that 
cast doubt on the reliability of their reporting. The four 
participants who reported improved health status each 
attributed this to a different reason, including consistent 
exercise, change in medication, surgical intervention or 
unknown factors. Several of those who reported them-
selves to be worse attributed this to a recent chest infec-
tion or health conditions other than COPD. Roughly 
one in five participants had been hospitalised since 
completing the WBS programme from either COPD or 
another health condition, in equal proportions. For two 
participants, COPD was reported to be of lesser concern 
compared with cataracts and heart disease, respectively.
Contact with the WBS and desire for further support
Electronic medical record data identified that 24 partici-
pants (75%) had been in contact with the WBS since the 
time of their first interview for reasons outside the research 
protocol mentioned above, 11 (34%) of whom initiated 
the contact and 13 (41%) of whom were contacted for 
follow- up by the WBS, including two who were seen while 
admitted to hospital. Nine participants were seen by the 
WBS psychologist. Six of the eight participants who did 
not have contact with the WBS had been seen by one or 
more of its affiliated services. Only two of the 32 partici-
pants interviewed had received no contact with WBS or its 
affiliated services since completing the programme.
Many participants lacked a clear memory of contacts 
with the WBS vis-à-vis other services, or which support 
they had received from each.
P23: I did better with it [hand- held fan] than not, so 
I went and bought one.
Interviewer: Right. So that was the Westmead Clinic 
that put you on to that in the first place?
P23: No … I don’t know. (P23, man in his mid 50s)
However, when prompted, most participants appeared 
to remember individual personnel at the WBS and 
repeated comments they had made at their initial inter-
view regarding their caring and supportive approach. 
When asked, all participants also expressed a belief that 
they could contact the WBS again for support whenever 
they needed to.
I know they’re there if I needed to call. (P21, woman 
in her late 60s)
The most common reason for not having initiated 
contact with the WBS was a belief that the service had 
Table 1 Participant characteristics (n=32)
Characteristic (summary measure)
Age (years) 70.6 (6.6)
Male (%) 61
Lives alone (%) 39
Long- term oxygen therapy (%) 12
Completed PR within past year (%) 36
FEV1 (L) 0.82 (0.32)
FEV1 (predicted) 31 (12)
VC (L) 2.32 (0.76)
VC (% predicted) 66 (15)
FEV1/VC (%) 36 (12)
6MWD (m) 304 (95)
mMRC (points) 3.5 (0.92)
Breathlessness NRS on exertion (points) 7.9 (1.7)
HADS anxiety and/or depression scores >7 
(%)
56
Data are presented as mean (SD), or % total group.
FEV1, forced expiratory volume in one second; HADS, Hospital 
Anxiety and Depression Scale (with scores >7 suggestive of 
symptoms in the clinical range); mMRC, modified Medical 
Research Council Dyspnoea Scale (0–4); 6MWD, 6- minute walk 
distance; NRS, 0–10 Numerical Rating Scale for severity; PR, 
pulmonary rehabilitation; VC, vital capacity.
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provided all the support it could and further contact 
would not be beneficial. Some participants expressed 
this in terms of feeling confident in self- managing their 
breathlessness without further assistance, whereas others 
framed it as themselves having given up on finding new 
ways to improve their ability to live with COPD.
They’ve given me all the tools. I know what to do, you 
know what I mean? (P12, woman in her late 60s)
I don’t feel it’s sort of getting any progress with it re-
ally. That’s the best way I can put it. (P16, woman in 
her early 80s)
One of the participants who still used strategies she had 
learnt from the WBS indicated that the written informa-
tion she had been given by the service reduced the need 
for further contact.
Sometimes I forget [the breathing techniques]. But 
then I just go to the programme thing that they gave 
me and I just do it. (P32, woman in her mid 70s)
Sustainability
All except two participants identified specific strate-
gies taught through the WBS that they still used to self- 
manage their breathlessness. Interestingly, this included 
one of two participants who had self- reported no benefit 
from the WBS when interviewed at the first time- point but 
who reported continuing use of breathing techniques, 
the hand- held fan, exercise, planning and pacing, and 
techniques for helping with showering at the 6- month 
time- point; this participant was also among those whose 
reports of overall change were deemed inconsistent 
when the entire transcript was rated by researchers. The 
other participant who had reported no benefit at the first 
time- point was among those who had not sustained any 
strategies, and now indicated that he was in the end- of- 
life phase. The second participant who did not report 
continuing use of any strategies appeared to have poor 
memory of the WBS and interviewer.
Among the strategies sustained, breathing techniques 
were in use by the largest number of participants (n=22; 
69%), followed by the hand- held fan (n=17; 53%), plan-
ning/pacing and exercise (n=14 for each; 44%) and stra-
tegic use of a walker (n=8; 25%), with two participants 
continuing sputum clearing techniques.
I got that [the hand- held fan] from the girls in the 
clinic … I have fans in every room, the little hand 
fans. I have one in my shopping bag in case I go to 
my daughter’s or somewhere. I always have one in my 
bag. I’ve got one in the bedroom, one in the little 
lounge room, and out in the courtyard. So, I’ve got a 
fan near me whenever I need it. (P02, woman in her 
mid 80s)
Psychological coping
Participants were especially divided on the degree to 
which they had sustained psychological benefits they had 
reported at the first interview. Almost a third of partic-
ipants reported problems with psychological coping. 
These participants included patients whose health status 
was unchanged and those who had declined in roughly 
equal proportions. Psychological challenges were typi-
cally described in terms of a difficulty with persevering 
over the long- term in the face of relentless breathlessness 
and impacts on daily life. This included the challenge of 
maintaining behaviour change over time and coping with 
relapse.
Yeah, and it’s this frustration. What I’m doing is not 
helping me. It is helping me out in combating it all, 
as the girls [from the WBS] have taught me, and that. 
And that does help, but it doesn’t get rid of the con-
stants of it all because I know as soon as I move it’s 
back again … But then I go and start smoking … And 
then I regret that ’cause then I burn, I can’t breathe 
at all, so back to the drawing board again. Then I start 
out and I get strong again and then it doesn’t last 
and then I get downhearted again. And it’s like a big 
circle I’m putting myself in, you know? (P04, man in 
his mid 60s)
In other cases, a loss in confidence was associated with a 
specific event, usually a chest infection and hospitalisation.
I was in the actual hospital. About 5 weeks ago now. 
And I’ve come good since but very gingerly … had 
a chest infection, I had a friend come to stay with 
a bloody cold … So I’ve been on major antibiotics 
since - medications, yeah, not easy … I just don’t 
have as much energy. I don’t eat like I used to, my 
taste buds are gone to, I don’t know, have gone south 
somewhere. Little things, my mobility is not the same. 
(P20, man in his early 60s)
This contrasted with a similar proportion of partici-
pants who reported themselves to be coping relatively 
well psychologically. While some participants were able to 
attribute this to perceived improvements in their general 
health, others referred to positive attitude or persistence 
in the face of little change or even decline.
I’ve still got my positive attitude and outlook; I’m not 
going to rest on my laurels, no. As I’ve been told by all 
and sundry, it’ll never sort of get back to what it was, 
but just the quality of life - that’s my main purpose in 
life at the moment, yeah. (P31, man in his early 70s)
Psychological intervention
Three participants reported that they had received 
support from the WBS psychologist in the intervening 
6 months. Two of these perceived that their self- 
management of anxiety had improved through learning 
relaxation and cognitive behavioural strategies; the third 
reported limited benefit.
She [the psychologist] was nice to talk to you, but 
I mean, I’m at the stage now where I don’t know if 
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anyone can really help that much, can they? That 
sounds a bit… I know it sounds like I’m feeling sor-
ry for myself, but I’m being realistic. What can I do? 
(P25, woman in her early 70s)
Four more participants who had been expecting to 
see the psychologist when interviewed at the first time- 
point reported deciding against this either because they 
didn’t believe it could assist them (n=3) or believed that 
they didn’t need it anymore (n=1). Two participants 
highlighted the deep- rooted nature of their psycholog-
ical challenges, and one also expressed a reluctance to 
disclose and explore potentially contributory distressing 
experiences, sometimes in early life.
There’s some very personal stuff that’s in my life, you 
know. (P07, man in his early 60s)
Several participants also referred to stigma and suspicion 
as barriers to accepting a psychology referral, including 
one man who had overcome this and benefitted.
One of the first things you say is ‘you’re not psycho-
logically profiling me here at the minute are you?’ 
Some FBI you know? … like they said, ‘it’s going to be 
an intervention’, and the word ‘intervention’ to old 
people feels like they’re going to get locked up put in 
a home! (P38, man in his early 60s)
DISCUSSION
This study extends previous qualitative research on the 
nature of benefits that patients perceive from attending 
breathlessness services8 13 16 by exploring the sustain-
ability of self- management strategies and benefits 6 
months afterwards in patients with moderate to very 
severe COPD. Most patients were continuing to use non- 
pharmacological strategies they had learnt at the WBS. 
However, almost a third of participants were found to be 
struggling psychologically. These patients appeared to 
have been showing reductions in what has been termed 
‘breathing space’, demonstrated through disengaged 
coping and a disinclination to seek help.17
Despite maintenance of psychological coping being 
an area of challenge, four patients had declined referral 
to a psychologist. This is consistent with the literature 
suggesting that around a third of eligible patients with 
COPD refuse CBT,18 with attrition rates of around 55%.19 
Our study follows at least one other20 in finding this to be 
partly attributable to a lack of perceived need for psycho-
logical intervention arising from a belief that interven-
tion will be futile or else that symptoms may not be severe 
enough to warrant assistance. Mistrust of psychologists 
and a reluctance to delve into personal histories were 
also barriers within the current sample. Recent research 
has increasingly focused on improving uptake of pulmo-
nary rehabilitation by people with COPD,21 but less so 
psychological intervention. Given evidence that CBT 
improves anxiety and depression in patients with COPD 
compared with usual care,22 more focus is needed on 
improving uptake through de- stigmatising mental health 
treatment among this older population and providing 
patient education aimed at helping patients to better 
understand: (1) the detrimental impact of mood on self- 
management; (2) ways in which psychological interven-
tion may be useful for managing chronic conditions and 
(3) differences between CBT and psychoanalysis; i.e. that 
the former focuses on making explicit and reframing less 
helpful thoughts, while the latter has a greater emphasis 
on delving into childhood history and making the uncon-
scious conscious.
The poor memory and confusion shown by many 
participants in this study regarding their health status 
over time is consistent with previous evidence that mild 
cognitive impairment is common in people with COPD.23 
Recall problems were extensive and pervasive throughout 
many interviews. In some cases, participants struggled 
to distinguish the WBS from other services or even to 
recall the WBS at all. This was especially surprising given 
participants’ praise for individual WBS personnel and 
strong therapeutic relationships reported in the initial 
interviews.13 Findings from our study on patients with 
COPD differs from research that has examined long- term 
maintenance of self- management education in patients 
with other chronic illnesses such as diabetes,24 25 none of 
which identified poor memory to be an important barrier 
to sustaining strategies despite finding other challenges 
(although these samples were significantly younger 
than our cohort, potentially accounting for some of the 
observed difference). If patients cannot recall changes 
in their recent health, they may also struggle to recall 
important health management activities (eg, complex 
medication regimens necessary to manage multiple 
comorbidities). The cognitive demand of CBT may also 
pose a barrier to people with cognitive impairment unless 
specific attention is given to modifying delivery.26 Further 
research is needed to integrate existing evidence- based 
recommendations that support people with cognitive 
impairment with strategies for self- managing chronic 
breathlessness.
The narratives told by our participants appeared similar 
to those of patients with COPD in a previous qualitative 
study by Pinnock et al 27 which found ‘chaos’ to be the 
prevailing characteristic. Pinnock et al built on work by 
Frank28 in identifying three illness narratives: a restitution 
narrative (“yesterday I was healthy, today I am sick, but 
tomorrow I will be healthy again”); a quest narrative (“I 
have a health problem but I’m using the experience to 
improve the situation [for myself or others]” and a chaos 
narrative (‘this happened. Later on this happened. And 
also this happened’) (p3).27 Although all three of these 
narratives were evident in our findings, the chaos narrative 
was especially prevalent. Like patients in Pinnock et al’s27 
sample, many participants in our study seemed to view 
the burden from COPD as a ‘way of life’ (p4), rather than 
as a stressor over which they retained control concerning 
their emotional response and impact on functioning. In 
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both studies, a chaos narrative was manifest as a sense of 
disempowerment in general and reduced self- efficacy for 
self- managing in particular. Participants needed repeated 
prompting to consider how self- management influenced 
their experience of living with breathlessness rather than 
default to more passively attributing impacts entirely to 
their disease. Their reports also tended to be fragmented 
rather than coherent and linear.
Educational and coaching intervention studies have 
commonly focused on improving self- efficacy as a prereq-
uisite for self- management skills in people with COPD,29 30 
with a small number demonstrating sustained improve-
ments over 6 months31 or even a year.32 However, such 
studies have rarely controlled for the degrees to which 
participants are self- efficacious at commencement, or 
attempted a ‘second dose’ to boost self- efficacy at follow- up 
in patients who have only partially or not responded. It 
seems likely that patients may be more or less predisposed 
to respond to self- management interventions depending 
on a range of psychological attributes that have been 
conceptualised variously as locus of control,33 readiness 
for change34 and dispositional coping style.35 ‘Activating’ 
a patient to become engaged in self- management may 
require a process that involves helping them: ‘(1) to 
believe the patient role is important; (2) have the confi-
dence and knowledge necessary to take action; (3) actu-
ally take action to maintain and improve one’s health and 
(4) stay the course even under stress’ (p1005).36 This study 
suggests that some patients who appear to make initial 
gains on the first three stages of activation may struggle 
to maintain the fourth. Greater attention may be needed 
to coach patients on the likelihood that they will face 
set- backs/relapses, together with practical strategies for 
remaining resilient. Further research is also required to 
evaluate whether booster self- management interventions 
for people who relapse offer a ‘high return on invest-
ment’ or a ‘diminishing return’. In a study that provided 
CBT- based ‘stepped care’ for anxiety and depression, 
most participants rejected the offer of further treatment 
when their symptoms recurred.20 However, neither this 
study nor many other CBT trials in COPD have measured 
patient self- efficacy.22 More research is needed on the 
complex and multidirectional relationships between the 
various constructs thought to underpin patients’ capacity 
to derive benefit, as well as the nature of difficulties faced 
by patients with severe COPD in sustaining psychological 
gains and self- management—for example, whether this is 
akin to ‘demoralisation syndrome’, which may require a 
dedicated management approach.37
This study has several strengths and weaknesses. The 
sample who provided interview data at 6- month follow- up 
in this study were drawn from a consecutive patient popu-
lation recruited to provide ‘information power’14 at the first 
time- point.13 Although there was 22% attrition between time- 
points, participants lost to follow- up did not appear to be 
biased towards those who reported greater or lesser benefit 
initially. The most important limitation of this study pertained 
to negative impacts on data quality of participants’ poor 
recall, potentially attributable to cognitive impairments and 
chaos narrative, as described above. Participants’ recollection 
of their contact with the WBS may have been complicated by 
the fact that some WBS staff also worked in affiliated services, 
such as the COPD Integrated Care Service and Respiratory 
Ambulatory Care Service. Also, interviewing by telephone 
limits non- verbal communication that might have served 
as additional cues for participant memory and enabled the 
interviewer to better assess whether participants were seeking 
to disguise memory loss, contributing to the richness of data. 
However, the interviewer was not involved in care so would 
have been unlikely to trigger recall of the service, and face- 
to- face interviews would not have been possible during the 
COVID-19 pandemic. Even after Australia was successful in 
controlling community cases, participants with respiratory 
disease were keen to maintain social isolation, and in- person 
contact was discouraged for research purposes. Although 
video conferencing could have been considered, some older 
participants have refused this option in our previous studies, 
leading to an inconsistent approach to data collection across 
participants. Using a qualitative approach, this study sought 
to give patients a ‘voice’, but no consumers were involved as 
coresearchers, and analysis used a professional ‘lens’. Finally, 
the WBS is the first breathlessness intervention service to be 
evaluated that specifically targets patients with COPD rather 
than a mixture of malignant and non- malignant diagnoses.6 7 
This limits generalisability of our findings to other patient 
populations but also enabled a more finely grained consider-
ation of COPD- specific issues.
In conclusion, this study builds on previous research to 
suggest that most patients with COPD who attend a breathless-
ness service continue to use at least some strategies 6 months 
afterwards. Maintenance of psychological coping appears to 
be more challenging and may occur within the context of 
attitudinal barriers to accepting psychological intervention 
along with challenges of behaviour change. Further research 
is needed to understand interactions between poor memory, 
cognitive decline and psychological coping, and the impact 
these may have on sustaining self- management.
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